2020-2025 Global RNA-interference (RNAi) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
2020-2025 Global RNA-interference (RNAi) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing, and quelling.
This report elaborates the market size, market characteristics, and market growth of the RNA-interference (RNAi) industry, and breaks down according to the type, application, and consumption area of RNA-interference (RNAi). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for RNA-interference (RNAi) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global RNA-interference (RNAi) market covered in Chapter 13:
Merck & Co. Inc. (Sigma Aldrich)
Dicerna Pharmaceuticals
RXI Pharmaceuticals
Quark Pharmaceuticals Inc.
Arrowhead
Ionis Pharmaceuticals Inc.
Qiagen NV
Arcturus Therapeutics
Phio Pharmaceuticals Corp.
Tekmira Pharmaceuticals Corporation
ISIS Pharmaceuticals
Silence Therapeutics PLC
Benitec Biopharma Ltd
Thermo Fisher Scientific Inc.
Alnylam Pharmaceuticals
In Chapter 6, on the basis of types, the RNA-interference (RNAi) market from 2015 to 2025 is primarily split into:
Chemical synthesis
In vitro transcription
In vivo expression
In Chapter 7, on the basis of applications, the RNA-interference (RNAi) market from 2015 to 2025 covers:
Drug Discovery and Development
Therapeutics
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 RNA-interference (RNAi) Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 RNA-interference (RNAi) Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 RNA-interference (RNAi) Market Forces
3.1 Global RNA-interference (RNAi) Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 RNA-interference (RNAi) Market - By Geography
4.1 Global RNA-interference (RNAi) Market Value and Market Share by Regions
4.1.1 Global RNA-interference (RNAi) Value ($) by Region (2015-2020)
4.1.2 Global RNA-interference (RNAi) Value Market Share by Regions (2015-2020)
4.2 Global RNA-interference (RNAi) Market Production and Market Share by Major Countries
4.2.1 Global RNA-interference (RNAi) Production by Major Countries (2015-2020)
4.2.2 Global RNA-interference (RNAi) Production Market Share by Major Countries (2015-2020)
4.3 Global RNA-interference (RNAi) Market Consumption and Market Share by Regions
4.3.1 Global RNA-interference (RNAi) Consumption by Regions (2015-2020)
4.3.2 Global RNA-interference (RNAi) Consumption Market Share by Regions (2015-2020)
5 RNA-interference (RNAi) Market - By Trade Statistics
5.1 Global RNA-interference (RNAi) Export and Import
5.2 United States RNA-interference (RNAi) Export and Import (2015-2020)
5.3 Europe RNA-interference (RNAi) Export and Import (2015-2020)
5.4 China RNA-interference (RNAi) Export and Import (2015-2020)
5.5 Japan RNA-interference (RNAi) Export and Import (2015-2020)
5.6 India RNA-interference (RNAi) Export and Import (2015-2020)
5.7
6 RNA-interference (RNAi) Market - By Type
6.1 Global RNA-interference (RNAi) Production and Market Share by Types (2015-2020)
6.1.1 Global RNA-interference (RNAi) Production by Types (2015-2020)
6.1.2 Global RNA-interference (RNAi) Production Market Share by Types (2015-2020)
6.2 Global RNA-interference (RNAi) Value and Market Share by Types (2015-2020)
6.2.1 Global RNA-interference (RNAi) Value by Types (2015-2020)
6.2.2 Global RNA-interference (RNAi) Value Market Share by Types (2015-2020)
6.3 Global RNA-interference (RNAi) Production, Price and Growth Rate of Chemical synthesis (2015-2020)
6.4 Global RNA-interference (RNAi) Production, Price and Growth Rate of In vitro transcription (2015-2020)
6.5 Global RNA-interference (RNAi) Production, Price and Growth Rate of In vivo expression (2015-2020)
7 RNA-interference (RNAi) Market - By Application
7.1 Global RNA-interference (RNAi) Consumption and Market Share by Applications (2015-2020)
7.1.1 Global RNA-interference (RNAi) Consumption by Applications (2015-2020)
7.1.2 Global RNA-interference (RNAi) Consumption Market Share by Applications (2015-2020)
7.2 Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2015-2020)
7.3 Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2015-2020)
8 North America RNA-interference (RNAi) Market
8.1 North America RNA-interference (RNAi) Market Size
8.2 United States RNA-interference (RNAi) Market Size
8.3 Canada RNA-interference (RNAi) Market Size
8.4 Mexico RNA-interference (RNAi) Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe RNA-interference (RNAi) Market Analysis
9.1 Europe RNA-interference (RNAi) Market Size
9.2 Germany RNA-interference (RNAi) Market Size
9.3 United Kingdom RNA-interference (RNAi) Market Size
9.4 France RNA-interference (RNAi) Market Size
9.5 Italy RNA-interference (RNAi) Market Size
9.6 Spain RNA-interference (RNAi) Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific RNA-interference (RNAi) Market Analysis
10.1 Asia-Pacific RNA-interference (RNAi) Market Size
10.2 China RNA-interference (RNAi) Market Size
10.3 Japan RNA-interference (RNAi) Market Size
10.4 South Korea RNA-interference (RNAi) Market Size
10.5 Southeast Asia RNA-interference (RNAi) Market Size
10.6 India RNA-interference (RNAi) Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa RNA-interference (RNAi) Market Analysis
11.1 Middle East and Africa RNA-interference (RNAi) Market Size
11.2 Saudi Arabia RNA-interference (RNAi) Market Size
11.3 UAE RNA-interference (RNAi) Market Size
11.4 South Africa RNA-interference (RNAi) Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America RNA-interference (RNAi) Market Analysis
12.1 South America RNA-interference (RNAi) Market Size
12.2 Brazil RNA-interference (RNAi) Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Merck & Co. Inc. (Sigma Aldrich)
13.1.1 Merck & Co. Inc. (Sigma Aldrich) Basic Information
13.1.2 Merck & Co. Inc. (Sigma Aldrich) Product Profiles, Application and Specification
13.1.3 Merck & Co. Inc. (Sigma Aldrich) RNA-interference (RNAi) Market Performance (2015-2020)
13.2 Dicerna Pharmaceuticals
13.2.1 Dicerna Pharmaceuticals Basic Information
13.2.2 Dicerna Pharmaceuticals Product Profiles, Application and Specification
13.2.3 Dicerna Pharmaceuticals RNA-interference (RNAi) Market Performance (2015-2020)
13.3 RXI Pharmaceuticals
13.3.1 RXI Pharmaceuticals Basic Information
13.3.2 RXI Pharmaceuticals Product Profiles, Application and Specification
13.3.3 RXI Pharmaceuticals RNA-interference (RNAi) Market Performance (2015-2020)
13.4 Quark Pharmaceuticals Inc.
13.4.1 Quark Pharmaceuticals Inc. Basic Information
13.4.2 Quark Pharmaceuticals Inc. Product Profiles, Application and Specification
13.4.3 Quark Pharmaceuticals Inc. RNA-interference (RNAi) Market Performance (2015-2020)
13.5 Arrowhead
13.5.1 Arrowhead Basic Information
13.5.2 Arrowhead Product Profiles, Application and Specification
13.5.3 Arrowhead RNA-interference (RNAi) Market Performance (2015-2020)
13.6 Ionis Pharmaceuticals Inc.
13.6.1 Ionis Pharmaceuticals Inc. Basic Information
13.6.2 Ionis Pharmaceuticals Inc. Product Profiles, Application and Specification
13.6.3 Ionis Pharmaceuticals Inc. RNA-interference (RNAi) Market Performance (2015-2020)
13.7 Qiagen NV
13.7.1 Qiagen NV Basic Information
13.7.2 Qiagen NV Product Profiles, Application and Specification
13.7.3 Qiagen NV RNA-interference (RNAi) Market Performance (2015-2020)
13.8 Arcturus Therapeutics
13.8.1 Arcturus Therapeutics Basic Information
13.8.2 Arcturus Therapeutics Product Profiles, Application and Specification
13.8.3 Arcturus Therapeutics RNA-interference (RNAi) Market Performance (2015-2020)
13.9 Phio Pharmaceuticals Corp.
13.9.1 Phio Pharmaceuticals Corp. Basic Information
13.9.2 Phio Pharmaceuticals Corp. Product Profiles, Application and Specification
13.9.3 Phio Pharmaceuticals Corp. RNA-interference (RNAi) Market Performance (2015-2020)
13.10 Tekmira Pharmaceuticals Corporation
13.10.1 Tekmira Pharmaceuticals Corporation Basic Information
13.10.2 Tekmira Pharmaceuticals Corporation Product Profiles, Application and Specification
13.10.3 Tekmira Pharmaceuticals Corporation RNA-interference (RNAi) Market Performance (2015-2020)
13.11 ISIS Pharmaceuticals
13.11.1 ISIS Pharmaceuticals Basic Information
13.11.2 ISIS Pharmaceuticals Product Profiles, Application and Specification
13.11.3 ISIS Pharmaceuticals RNA-interference (RNAi) Market Performance (2015-2020)
13.12 Silence Therapeutics PLC
13.12.1 Silence Therapeutics PLC Basic Information
13.12.2 Silence Therapeutics PLC Product Profiles, Application and Specification
13.12.3 Silence Therapeutics PLC RNA-interference (RNAi) Market Performance (2015-2020)
13.13 Benitec Biopharma Ltd
13.13.1 Benitec Biopharma Ltd Basic Information
13.13.2 Benitec Biopharma Ltd Product Profiles, Application and Specification
13.13.3 Benitec Biopharma Ltd RNA-interference (RNAi) Market Performance (2015-2020)
13.14 Thermo Fisher Scientific Inc.
13.14.1 Thermo Fisher Scientific Inc. Basic Information
13.14.2 Thermo Fisher Scientific Inc. Product Profiles, Application and Specification
13.14.3 Thermo Fisher Scientific Inc. RNA-interference (RNAi) Market Performance (2015-2020)
13.15 Alnylam Pharmaceuticals
13.15.1 Alnylam Pharmaceuticals Basic Information
13.15.2 Alnylam Pharmaceuticals Product Profiles, Application and Specification
13.15.3 Alnylam Pharmaceuticals RNA-interference (RNAi) Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America RNA-interference (RNAi) Market Forecast (2020-2025)
14.2 Europe RNA-interference (RNAi) Market Forecast (2020-2025)
14.3 Asia-Pacific RNA-interference (RNAi) Market Forecast (2020-2025)
14.4 Middle East and Africa RNA-interference (RNAi) Market Forecast (2020-2025)
14.5 South America RNA-interference (RNAi) Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global RNA-interference (RNAi) Market Forecast by Types (2020-2025)
15.1.1 Global RNA-interference (RNAi) Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global RNA-interference (RNAi) Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global RNA-interference (RNAi) Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure RNA-interference (RNAi) Picture
Table RNA-interference (RNAi) Key Market Segments
Figure Study and Forecasting Years
Figure Global RNA-interference (RNAi) Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global RNA-interference (RNAi) Value ($) and Growth Rate (2015-2020)
Table Global RNA-interference (RNAi) Value ($) by Countries (2015-2020)
Table Global RNA-interference (RNAi) Value Market Share by Regions (2015-2020)
Figure Global RNA-interference (RNAi) Value Market Share by Regions in 2019
Figure Global RNA-interference (RNAi) Production and Growth Rate (2015-2020)
Table Global RNA-interference (RNAi) Production by Major Countries (2015-2020)
Table Global RNA-interference (RNAi) Production Market Share by Major Countries (2015-2020)
Figure Global RNA-interference (RNAi) Production Market Share by Regions in 2019
Figure Global RNA-interference (RNAi) Consumption and Growth Rate (2015-2020)
Table Global RNA-interference (RNAi) Consumption by Regions (2015-2020)
Table Global RNA-interference (RNAi) Consumption Market Share by Regions (2015-2020)
Figure Global RNA-interference (RNAi) Consumption Market Share by Regions in 2019
Table Global RNA-interference (RNAi) Export Top 3 Country 2019
Table Global RNA-interference (RNAi) Import Top 3 Country 2019
Table United States RNA-interference (RNAi) Export and Import (2015-2020)
Table Europe RNA-interference (RNAi) Export and Import (2015-2020)
Table China RNA-interference (RNAi) Export and Import (2015-2020)
Table Japan RNA-interference (RNAi) Export and Import (2015-2020)
Table India RNA-interference (RNAi) Export and Import (2015-2020)
Table Global RNA-interference (RNAi) Production by Types (2015-2020)
Table Global RNA-interference (RNAi) Production Market Share by Types (2015-2020)
Figure Global RNA-interference (RNAi) Production Share by Type (2015-2020)
Table Global RNA-interference (RNAi) Value by Types (2015-2020)
Table Global RNA-interference (RNAi) Value Market Share by Types (2015-2020)
Figure Global RNA-interference (RNAi) Value Share by Type (2015-2020)
Figure Global Chemical synthesis Production and Growth Rate (2015-2020)
Figure Global Chemical synthesis Price (2015-2020)
Figure Global In vitro transcription Production and Growth Rate (2015-2020)
Figure Global In vitro transcription Price (2015-2020)
Figure Global In vivo expression Production and Growth Rate (2015-2020)
Figure Global In vivo expression Price (2015-2020)
Table Global RNA-interference (RNAi) Consumption by Applications (2015-2020)
Table Global RNA-interference (RNAi) Consumption Market Share by Applications (2015-2020)
Figure Global RNA-interference (RNAi) Consumption Share by Application (2015-2020)
Figure Global Drug Discovery and Development Consumption and Growth Rate (2015-2020)
Figure Global Therapeutics Consumption and Growth Rate (2015-2020)
Figure North America RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Table North America RNA-interference (RNAi) Consumption by Countries (2015-2020)
Table North America RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure North America RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure United States RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure Canada RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure Mexico RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Table Europe RNA-interference (RNAi) Consumption by Countries (2015-2020)
Table Europe RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure Europe RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure Germany RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure France RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure Italy RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure Spain RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Consumption by Countries (2015-2020)
Table Asia-Pacific RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure China RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure Japan RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure South Korea RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure India RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa RNA-interference (RNAi) Consumption by Countries (2015-2020)
Table Middle East and Africa RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure UAE RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure South Africa RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Figure South America RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Table South America RNA-interference (RNAi) Consumption by Countries (2015-2020)
Table South America RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure South America RNA-interference (RNAi) Consumption Market Share by Countries (2015-2020)
Figure Brazil RNA-interference (RNAi) Market Consumption and Growth Rate (2015-2020)
Table Merck & Co. Inc. (Sigma Aldrich) Company Profile
Table Merck & Co. Inc. (Sigma Aldrich) Production, Value, Price, Gross Margin 2015-2020
Figure Merck & Co. Inc. (Sigma Aldrich) Production and Growth Rate
Figure Merck & Co. Inc. (Sigma Aldrich) Value ($) Market Share 2015-2020
Table Dicerna Pharmaceuticals Company Profile
Table Dicerna Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Dicerna Pharmaceuticals Production and Growth Rate
Figure Dicerna Pharmaceuticals Value ($) Market Share 2015-2020
Table RXI Pharmaceuticals Company Profile
Table RXI Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure RXI Pharmaceuticals Production and Growth Rate
Figure RXI Pharmaceuticals Value ($) Market Share 2015-2020
Table Quark Pharmaceuticals Inc. Company Profile
Table Quark Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Quark Pharmaceuticals Inc. Production and Growth Rate
Figure Quark Pharmaceuticals Inc. Value ($) Market Share 2015-2020
Table Arrowhead Company Profile
Table Arrowhead Production, Value, Price, Gross Margin 2015-2020
Figure Arrowhead Production and Growth Rate
Figure Arrowhead Value ($) Market Share 2015-2020
Table Ionis Pharmaceuticals Inc. Company Profile
Table Ionis Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Ionis Pharmaceuticals Inc. Production and Growth Rate
Figure Ionis Pharmaceuticals Inc. Value ($) Market Share 2015-2020
Table Qiagen NV Company Profile
Table Qiagen NV Production, Value, Price, Gross Margin 2015-2020
Figure Qiagen NV Production and Growth Rate
Figure Qiagen NV Value ($) Market Share 2015-2020
Table Arcturus Therapeutics Company Profile
Table Arcturus Therapeutics Production, Value, Price, Gross Margin 2015-2020
Figure Arcturus Therapeutics Production and Growth Rate
Figure Arcturus Therapeutics Value ($) Market Share 2015-2020
Table Phio Pharmaceuticals Corp. Company Profile
Table Phio Pharmaceuticals Corp. Production, Value, Price, Gross Margin 2015-2020
Figure Phio Pharmaceuticals Corp. Production and Growth Rate
Figure Phio Pharmaceuticals Corp. Value ($) Market Share 2015-2020
Table Tekmira Pharmaceuticals Corporation Company Profile
Table Tekmira Pharmaceuticals Corporation Production, Value, Price, Gross Margin 2015-2020
Figure Tekmira Pharmaceuticals Corporation Production and Growth Rate
Figure Tekmira Pharmaceuticals Corporation Value ($) Market Share 2015-2020
Table ISIS Pharmaceuticals Company Profile
Table ISIS Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure ISIS Pharmaceuticals Production and Growth Rate
Figure ISIS Pharmaceuticals Value ($) Market Share 2015-2020
Table Silence Therapeutics PLC Company Profile
Table Silence Therapeutics PLC Production, Value, Price, Gross Margin 2015-2020
Figure Silence Therapeutics PLC Production and Growth Rate
Figure Silence Therapeutics PLC Value ($) Market Share 2015-2020
Table Benitec Biopharma Ltd Company Profile
Table Benitec Biopharma Ltd Production, Value, Price, Gross Margin 2015-2020
Figure Benitec Biopharma Ltd Production and Growth Rate
Figure Benitec Biopharma Ltd Value ($) Market Share 2015-2020
Table Thermo Fisher Scientific Inc. Company Profile
Table Thermo Fisher Scientific Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Thermo Fisher Scientific Inc. Production and Growth Rate
Figure Thermo Fisher Scientific Inc. Value ($) Market Share 2015-2020
Table Alnylam Pharmaceuticals Company Profile
Table Alnylam Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Alnylam Pharmaceuticals Production and Growth Rate
Figure Alnylam Pharmaceuticals Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global RNA-interference (RNAi) Market Forecast Production by Types (2020-2025)
Table Global RNA-interference (RNAi) Market Forecast Production Share by Types (2020-2025)
Table Global RNA-interference (RNAi) Market Forecast Value ($) by Types (2020-2025)
Table Global RNA-interference (RNAi) Market Forecast Value Share by Types (2020-2025)
Table Global RNA-interference (RNAi) Market Forecast Consumption by Applications (2020-2025)
Table Global RNA-interference (RNAi) Market Forecast Consumption Share by Applications (2020-2025)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|